Literature DB >> 21205829

Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms.

Helen J Bradley1, Jocelyn M Baldwin1, G Ranjan Goli1, Brian Johnson1, Jie Zou1, Asipu Sivaprasadarao1, Stephen A Baldwin1, Lin-Hua Jiang2.   

Abstract

P2X(7) receptors are important in mediating the physiological functions of extracellular ATP, and altered receptor expression and function have a causative role in the disease pathogenesis. Here, we investigated the mechanisms determining the P2X(7) receptor function by following two human single-nucleotide polymorphism (SNP) mutations that replace His-155 and Ala-348 in the human (h) P2X(7) receptor with the corresponding residues, Tyr-155 and Thr-348, in the rat (r) P2X(7) receptor. H155Y and A348T mutations in the hP2X(7) receptor increased ATP-induced currents, whereas the reciprocal mutations, Y155H and T348A, in the rP2X(7) receptor caused the opposite effects. Such a functional switch is a compelling indication that these residues are critical for P2X(7) receptor function. Additional mutations of His-155 and Ala-348 in the hP2X(7) receptor to residues with diverse side chains revealed a different dependence on the side chain properties, supporting the specificity of these two residues. Substitutions of the residues surrounding His-155 and Ala-348 in the hP2X(7) receptor with the equivalent ones in the rP2X(7) receptor also affected ATP-induced currents but were not fully reminiscent of the H155Y and A348T effects. Immunofluorescence imaging and biotin labeling assays showed that H155Y in the hP2X(7) receptor increased and Y155H in the rP2X(7) receptor decreased cell-surface expression. Such contrasting effects were not obvious with the reciprocal mutations of residue 348. Taken together, our results suggest that residues at positions 155 and 348 contribute to P2X(7) receptor function via determining the surface expression and the single-channel function, respectively. Such interpretations are consistent with the locations of the residues in the structural model of the hP2X(7) receptor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21205829      PMCID: PMC3048704          DOI: 10.1074/jbc.M110.211284

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.

Authors:  Yong Chen; Xiaofei Zhang; Congying Wang; Guangwen Li; Yanping Gu; Li-Yen Mae Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

Review 2.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

3.  P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

Authors:  Susanne Lucae; Daria Salyakina; Nicholas Barden; Mario Harvey; Bernard Gagné; Michel Labbé; Elisabeth B Binder; Manfred Uhr; Marcelo Paez-Pereda; Inge Sillaber; Marcus Ising; Tanja Brückl; Roselind Lieb; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

4.  P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.

Authors:  Elena Adinolfi; Loredana Melchiorri; Simonetta Falzoni; Paola Chiozzi; Anna Morelli; Alessia Tieghi; Antonio Cuneo; Gianluigi Castoldi; Francesco Di Virgilio; Olavio R Baricordi
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

5.  Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP.

Authors:  Mark T Young; Pablo Pelegrin; Annmarie Surprenant
Journal:  Mol Pharmacol       Date:  2006-10-10       Impact factor: 4.436

6.  Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder.

Authors:  Nicholas Barden; Mario Harvey; Bernard Gagné; Eric Shink; Monique Tremblay; Catherine Raymond; Michel Labbé; André Villeneuve; Denis Rochette; Lise Bordeleau; Herbert Stadler; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

7.  Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain.

Authors:  Hyun B Choi; Jae K Ryu; Seung U Kim; James G McLarnon
Journal:  J Neurosci       Date:  2007-05-02       Impact factor: 6.167

8.  Homotrimeric complexes are the dominant assembly state of native P2X7 subunits.

Authors:  Annette Nicke
Journal:  Biochem Biophys Res Commun       Date:  2008-10-18       Impact factor: 3.575

9.  An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.

Authors:  Ben J Gu; Ronald Sluyter; Kristen K Skarratt; Anne N Shemon; Lan-Phuong Dao-Ung; Stephen J Fuller; Julian A Barden; Alison L Clarke; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

10.  Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia.

Authors:  X Zhang; Y Chen; C Wang; L-Y M Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-24       Impact factor: 11.205

View more
  21 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.

Authors:  Robert E Sorge; Tuan Trang; Ruslan Dorfman; Shad B Smith; Simon Beggs; Jennifer Ritchie; Jean-Sebastien Austin; Dmitri V Zaykin; Heather Vander Meulen; Michael Costigan; Teri A Herbert; Merav Yarkoni-Abitbul; David Tichauer; Jessica Livneh; Edith Gershon; Ming Zheng; Keith Tan; Sally L John; Gary D Slade; Joanne Jordan; Clifford J Woolf; Gary Peltz; William Maixner; Luda Diatchenko; Ze'ev Seltzer; Michael W Salter; Jeffrey S Mogil
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

3.  Association of P2RX7 functional variants with localized aggressive periodontitis.

Authors:  Theodore H Harris; Margaret R Wallace; Hong Huang; Hua Li; Azeem Mohiuddeen; Yan Gong; Theodora Kompotiati; Peter Harrison; Ikramuddin Aukhil; Luciana M Shaddox
Journal:  J Periodontal Res       Date:  2019-07-10       Impact factor: 4.419

4.  Zinc inactivates melastatin transient receptor potential 2 channels via the outer pore.

Authors:  Wei Yang; Paul T Manna; Jie Zou; Jianhong Luo; David J Beech; Asipu Sivaprasadarao; Lin-Hua Jiang
Journal:  J Biol Chem       Date:  2011-05-20       Impact factor: 5.157

5.  Pharmacological properties of the rhesus macaque monkey P2X7 receptor.

Authors:  Helen J Bradley; Liam E Browne; Wei Yang; Lin-Hua Jiang
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis.

Authors:  Ralf Hausmann; Achim Kless; Gunther Schmalzing
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

7.  Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl.

Authors:  Soichiro Ide; Daisuke Nishizawa; Ken-ichi Fukuda; Shinya Kasai; Junko Hasegawa; Masakazu Hayashida; Masabumi Minami; Kazutaka Ikeda
Journal:  Mol Pain       Date:  2014-12-03       Impact factor: 3.395

8.  The second transmembrane domain of P2X7 contributes to dilated pore formation.

Authors:  Chengqun Sun; Michelle E Heid; Peter A Keyel; Russell D Salter
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

9.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

10.  Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.

Authors:  Daniel Ursu; Philip Ebert; Emily Langron; Cara Ruble; Leanne Munsie; Wei Zou; Bonnie Fijal; Yue-Wei Qian; Terry A McNearney; Adrian Mogg; Olivera Grubisha; Kalpana Merchant; Emanuele Sher
Journal:  Mol Pain       Date:  2014-06-16       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.